79 related articles for article (PubMed ID: 9789124)
1. Economic evaluations in medicine: still more questions than answers?
Grossi E
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):347-50. PubMed ID: 9789124
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia.
Mahadeva S; Chia YC; Vinothini A; Mohazmi M; Goh KL
Gut; 2008 Sep; 57(9):1214-20. PubMed ID: 18441005
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ
Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
[TBL] [Abstract][Full Text] [Related]
4. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
Vakil N; Zullo A; Ricci C; Hassan C; Vaira D
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1304-8. PubMed ID: 18774949
[TBL] [Abstract][Full Text] [Related]
5. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia.
Ford AC; Moayyedi P; Jarbol DE; Logan RF; Delaney BC
Aliment Pharmacol Ther; 2008 Sep; 28(5):534-44. PubMed ID: 18616641
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
8. Implications for treatment: pH, Helicobacter pylori or alternative approaches?
Chey WD
Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():17-8, 21-4. PubMed ID: 15755271
[No Abstract] [Full Text] [Related]
9. [Pharmacoeconomics in the therapy of peptic ulcer].
Tesar T; Foltán V; Huorka M
Ceska Slov Farm; 2002 Mar; 51(2):78-83. PubMed ID: 11928281
[TBL] [Abstract][Full Text] [Related]
10. Clinical inquiries. Is therapy based on endoscopy results better than empiric therapy for dyspepsia?
Rich K; Safranek S; Malaty W
J Fam Pract; 2005 Aug; 54(8):725-6. PubMed ID: 16061065
[No Abstract] [Full Text] [Related]
11. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
Arch Intern Med; 2003 May; 163(10):1165-71. PubMed ID: 12767952
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori eradication in ulcer patients. Quality of life improves, costs decline].
MMW Fortschr Med; 2003 Aug; 145(33-34):55. PubMed ID: 14526577
[No Abstract] [Full Text] [Related]
14. [The use of modern economic methods for the rational choice of drugs].
Khveshchuk PF; Rudakova AV; Galin AL
Voen Med Zh; 1999 Aug; 320(8):54-9. PubMed ID: 10524003
[No Abstract] [Full Text] [Related]
15. [Should Helicobacter pylori be eradicated in patients with functional dyspepsia?].
Elizalde I; Borda F
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():43-6. PubMed ID: 11968334
[No Abstract] [Full Text] [Related]
16. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
Cutler AF; Vakil N
Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
[TBL] [Abstract][Full Text] [Related]
17. Management strategies for duodenal ulcer in India in the helicobacter pylori era: an economic analysis.
Ghoshal UC; Das A
Natl Med J India; 2002; 15(3):140-4. PubMed ID: 12186326
[TBL] [Abstract][Full Text] [Related]
18. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?
Breuer T; Graham DY
Am J Gastroenterol; 1999 Mar; 94(3):725-9. PubMed ID: 10086658
[TBL] [Abstract][Full Text] [Related]
19. Eradication therapy for Helicobacter pylori.
Vakil N; Megraud F
Gastroenterology; 2007 Sep; 133(3):985-1001. PubMed ID: 17854602
[TBL] [Abstract][Full Text] [Related]
20. [Should Helicobacter pylori infection be considered in the management of dyspeptic patients?].
De Korwin JD
Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C79-94. PubMed ID: 10880917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
